Literature DB >> 15050723

Immunolocalization of CCK1R in rat brain using a new anti-peptide antibody.

Linda D Mercer1, Philip M Beart.   

Abstract

An antibody directed at the carboxy tail of the cholecystokinin-1 receptor (CCK1R) was characterized by ELISA and Western blotting. Immunohistochemistry established that CCK1R-like immunoreactivity (CCK1R-LI) was widely and topographically distributed through the neuroaxis, appearing relatively higher in rhi- and diencephalon, and intense in both neuronal somata (cytoplasmic) and processes. CCK1R-LI was found in new loci, but also in areas previously identified by receptor autoradiography, electrophysiology and in situ hybridization of CCK1R mRNA. The widespread distribution of CCK1R has implications for the functional roles of these receptors in brain. The high titre and low background seen with this new antiserum makes it of great value for cell and tissue research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050723     DOI: 10.1016/j.neulet.2004.01.045

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Electroacupuncture modulation of reflex hypertension in rats: role of cholecystokinin octapeptide.

Authors:  Min Li; Stephanie C Tjen-A-Looi; Zhi-Ling Guo; John C Longhurst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

Review 2.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

Review 3.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

4.  Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.

Authors:  Vanessa A Mitchell; Hyo-Jin Jeong; Geoffrey M Drew; Christopher W Vaughan
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

5.  Transmembrane Domain 3 Is a Transplantable Pharmacophore in the Photodynamic Activation of Cholecystokinin 1 Receptor.

Authors:  Yuan Li; Zong Jie Cui
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-08

Review 6.  CCK2 receptors in chronic pain.

Authors:  Justin E LaVigne; Sascha R A Alles
Journal:  Neurobiol Pain       Date:  2022-05-05

7.  Cholecystokinin action on layer 6b neurons in somatosensory cortex.

Authors:  Leeyup Chung; Scott D Moore; Charles L Cox
Journal:  Brain Res       Date:  2009-06-02       Impact factor: 3.252

8.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

9.  Cholecystokinin: an excitatory modulator of mitral/tufted cells in the mouse olfactory bulb.

Authors:  Jie Ma; Luba Dankulich-Nagrudny; Graeme Lowe
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

10.  Decreased expression of the satiety signal receptor CCKAR is responsible for increased growth and body weight during the domestication of chickens.

Authors:  Ian C Dunn; Simone L Meddle; Peter W Wilson; Chloe A Wardle; Andy S Law; Valerie R Bishop; Camilla Hindar; Graeme W Robertson; Dave W Burt; Stephanie J H Ellison; David M Morrice; Paul M Hocking
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.